Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
21.85
+1.04 (5.00%)
At close: Jun 18, 2026
-22.24% (1Y)
| Market Cap | 8.01B -23.5% |
| Revenue (ttm) | 277.82M +452.9% |
| Net Income | -564.33M |
| EPS | -1.54 |
| Shares Out | 366.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,014,594 |
| Open | 20.70 |
| Previous Close | 20.81 |
| Day's Range | 20.39 - 22.71 |
| 52-Week Range | 20.39 - 37.88 |
| Beta | 0.59 |
| Analysts | Strong Buy |
| Price Target | 40.00 (+83.07%) |
| Earnings Date | Aug 28, 2026 |